Luyan Pharma Co Ltd (SHE:002788) — Market Cap & Net Worth
Market Cap & Net Worth: Luyan Pharma Co Ltd (002788)
Luyan Pharma Co Ltd (SHE:002788) has a market capitalization of $593.54 Million (CN¥4.06 Billion) as of September 16, 2026. Listed on the SHE stock exchange, this China-based company holds position #11380 globally and #3174 in its home market, demonstrating a -9.53% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Luyan Pharma Co Ltd's stock price CN¥10.44 by its total outstanding shares 388516736 (388.52 Million). Also see 002788 total asset value for a full breakdown of the balance sheet.
Luyan Pharma Co Ltd Market Cap History: 2016 to 2026
Luyan Pharma Co Ltd's market capitalization history from 2016 to 2026. Data shows growth from $1.03 Billion to $593.54 Million (2.30% CAGR). Also see Luyan Pharma Co Ltd (002788) cash conversion ratio for how efficiently the company converts equity into cash flow.
Luyan Pharma Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Luyan Pharma Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check Luyan Pharma Co Ltd stock quote for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.06x
Luyan Pharma Co Ltd's market cap is 0.06 times its annual revenue
Latest Price to Earnings (P/E) Ratio
4.29x
Luyan Pharma Co Ltd's market cap is 4.29 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $1.03 Billion | $6.98 Billion | $115.52 Million | 0.15x | 8.90x |
| 2017 | $520.28 Million | $8.34 Billion | $130.58 Million | 0.06x | 3.98x |
| 2018 | $334.17 Million | $11.50 Billion | $180.32 Million | 0.03x | 1.85x |
| 2019 | $371.65 Million | $15.01 Billion | $255.89 Million | 0.02x | 1.45x |
| 2020 | $395.63 Million | $15.54 Billion | $266.63 Million | 0.03x | 1.48x |
| 2021 | $398.98 Million | $17.55 Billion | $305.87 Million | 0.02x | 1.30x |
| 2022 | $441.18 Million | $19.46 Billion | $345.16 Million | 0.02x | 1.28x |
| 2023 | $491.96 Million | $19.85 Billion | $363.53 Million | 0.02x | 1.35x |
| 2024 | $466.76 Million | $20.47 Billion | $345.64 Million | 0.02x | 1.35x |
| 2025 | $1.20 Billion | $21.25 Billion | $280.88 Million | 0.06x | 4.29x |
Competitor Companies of 002788 by Market Capitalization
Companies near Luyan Pharma Co Ltd in the global market cap rankings as of September 16, 2026. Review how tangible is Luyan Pharma Co Ltd's equity to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Luyan Pharma Co Ltd by market ranking:
- JD HEALTH INTL LTD (F:8ZN): Ranked #1929 globally with a market cap of $12.04 Billion USD ( €10.30 Billion EUR).
- Walgreens Boots Alliance Inc (NASDAQ:WBA): Ranked #2172 globally with a market cap of $10.37 Billion USD.
- ALIB.HL.INF.TEC.UNSP.ADR (F:TWYA): Ranked #2541 globally with a market cap of $8.42 Billion USD ( €7.20 Billion EUR).
- Raia Drogasil S.A (SA:RADL3): Ranked #2963 globally with a market cap of $6.67 Billion USD ( R$34.01 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #1929 | JD HEALTH INTL LTD | F:8ZN | $12.04 Billion | €3.80 |
| #2172 | Walgreens Boots Alliance Inc | NASDAQ:WBA | $10.37 Billion | $11.98 |
| #2541 | ALIB.HL.INF.TEC.UNSP.ADR | F:TWYA | $8.42 Billion | €8.95 |
| #2963 | Raia Drogasil S.A | SA:RADL3 | $6.67 Billion | R$19.45 |
Luyan Pharma Co Ltd Historical Marketcap From 2016 to 2026
Between 2016 and today, Luyan Pharma Co Ltd's market cap moved from $1.03 Billion to $ 593.54 Million, with a yearly change of 2.30%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥593.54 Million | -50.71% |
| 2025 | CN¥1.20 Billion | +157.98% |
| 2024 | CN¥466.76 Million | -5.12% |
| 2023 | CN¥491.96 Million | +11.51% |
| 2022 | CN¥441.18 Million | +10.58% |
| 2021 | CN¥398.98 Million | +0.85% |
| 2020 | CN¥395.63 Million | +6.45% |
| 2019 | CN¥371.65 Million | +11.22% |
| 2018 | CN¥334.17 Million | -35.77% |
| 2017 | CN¥520.28 Million | -49.42% |
| 2016 | CN¥1.03 Billion | -- |
End of Day Market Cap According to Different Sources
On Sep 16th, 2026 the market cap of Luyan Pharma Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $593.54 Million USD |
| MoneyControl | $593.54 Million USD |
| MarketWatch | $593.54 Million USD |
| marketcap.company | $593.54 Million USD |
| Reuters | $593.54 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Luyan Pharma Co Ltd
Luyan Pharma Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of pharmaceutical products, and prepared slices of traditional Chinese medicine in China. The company distributes medicines, Chinese herbal medicines, medical devices, and others; and provides medical care, elderly care, and wellness services. It also operates pharmaceutical retail ch… Read more